Bioprocessing of New Medicines (Business and Management) BSc
This programme is designed to give you a firm grounding in both the science of bioprocessing and the management of new emerging technologies in healthcare. You will develop an understanding of the latest biomedical and diagnostic advances, together with the business skills necessary for health and clinical research management.
Covid-19 programme updates
For the most up-to-date advice and information concerning UCL's response to the coronavirus outbreak please go to the Coronavirus (Covid-19) information pages. There is a Frequently Asked Questions section for prospective students and schools.
- UCAS code
Full-time: 3 years
- Application deadline
- 29 January 2021
- London, Bloomsbury
- Biology, Chemistry or Physics required.
- English Language and Mathematics at grade C or 5.
- ABB (more about contextual offers)
- Grade A in one from Biology, Chemistry or Physics required.
- English Language and Mathematics at grade C or 5.
- A total of 18 points in three higher level subjects including grade 6 in one from Biology, Chemistry or Physics, with no score below 5.
- 34 (more about contextual offers)
- A total of 16 points in three higher level subjects including grade 6 in one from Biology, Chemistry or Physics, with no score below 5.
UK applicants qualifications
For entry requirements with other UK qualifications accepted by UCL, choose your qualification from the list below:
Not acceptable for entrance to this programme.
Not acceptable for entrance to this programme.
D3,D3,D3 in three Cambridge Pre-U Principal Subjects, including one from Biology, Chemistry or Physics.
AAA at Advanced Highers (AA at Advanced Higher and AAA at Higher), including one of Biology, Chemistry or Physics at Advanced Higher.
Successful completion of the WBQ Advanced Skills Challenge Certificate plus 2 GCE A-Levels at grades AAA, including one of Biology, Chemistry or Physics.
In addition to A level and International Baccalaureate, UCL considers a wide range of international qualifications for entry to its undergraduate degree programmes.
Undergraduate Preparatory Certificates
UCL Undergraduate Preparatory Certificates (UPCs) are intensive one-year foundation courses for international students of high academic potential who are aiming to gain access to undergraduate degree programmes at UCL and other top UK universities.
Typical UPC students will be high achievers in a 12-year school system which does not meet the standard required for direct entry to UCL.
For more information see: www.ucl.ac.uk/upc.
English language requirements
If your education has not been conducted in the English language, you will be expected to demonstrate evidence of an adequate level of English proficiency. Information about the evidence required, acceptable qualifications and test providers can be found on our English language requirements page.
The English language level for this programme is: Standard
A variety of English language programmes are offered at the UCL Centre for Languages & International Education.
This BSc is a truly interdisciplinary programme. It draws on the knowledge of experts from across UCL in science, engineering, management and humanities.
The department has among the most modern and comprehensive biochemical engineering facilities of any university in the world. Valued at over £35 million, our facilities attract leading industrial collaborators.
Our teaching is designed to help you work at a detailed analytical level and also see the bigger picture in terms of addressing environmental and ethical issues.
We have been pioneers in providing our undergraduates with training to help them understand the business environment in which the life science industries operate. Through innovative teaching, and problem-based learning exercises we will prepare you better for your future career.
In each year of your degree you will take a number of individual modules, normally valued at 15 or 30 credits, adding up to a total of 120 credits for the year. Modules are assessed in the academic year in which they are taken. The balance of compulsory and optional modules varies from programme to programme and year to year. A 30-credit module is considered equivalent to 15 credits in the European Credit Transfer System (ECTS).
In the first year, you will study the basics of how a drug is created, made at scale and what the challenges of creating new medicines are. You will also study the prerequisite management principles involved in running an organisation and dealing with the accounts, as well as the fundamentals of data management.
In year two, you will study the internal and external factors that govern pharmaceutical production, with emphasis on clinical needs and their constraints. A wide spectrum of knowledge is encompassed from statistical analysis to legal and ethical concerns. You will also grow to understand the role of the internet in globalisation and access to medicines.
The third year addresses a more in-depth understanding of global practices, business planning, and the feasibility and economics of creating therapeutics and vaccines in both developed as well as developing markets. You will also undertake an independent bioprocess research project.
Upon successful completion of 360 credits, you will be awarded a BSc (Hons) in Bioprocessing of New Medicines (Business and Management).
Please note that the list of modules given here is indicative. This information is published a long time in advance of enrolment and module content and availability is subject to change.
- Accounting for Business
- Biochemistry and Molecular Biology
- Communication and Behaviour in Organisations
- Introduction to Biochemical Engineering
- Introduction to Biochemical Engineering Processing and Design
- Introductory Statistical Methods and Computing
- Understanding Management
You will select 15 credits from a range of options
- Cell Production Growth
- Downstream Processing
- Commercialisation of Research Ideas
- Law for Managers
- Manufacturing Regenerative Medicines: from Lab Bench to Industry
- Strategic Human Resource Management
You will select two modules of 15 credits each from a range of options
- Advanced Enterprise Implementation
- Bioprocess Design Study
- Bioprocess Research Project
- Business Planning in Bioprocessing and Life Sciences
- Project Management
- Vaccine Bioprocessing
You will select 15 credits from a range of options.
You will be taught through a combination of lectures, case studies, team-based projects and experiments. Leading industrialists and researchers regularly visit the department to provide guest lectures. Case studies are conducted in small teams, and your personal and departmental tutors are available to offer individual support.
Diverse forms of assessments linked to learning outcomes are designed to test a broad range of skills. Modules at the start of the degree are assessed via 2-3 pieces of coursework and an unseen examination at the end of the year. Problem-based activities may be assessed by individual or group reports, oral or poster presentations.
Detailed module descriptions are available on the department website: Bioprocessing of New Medicines (Business and Management) BSc.
The core science, engineering, business and leadership skills that you acquire on the programme will provide you with excellent and diverse career prospects. In addition to your core subject knowledge, the programme will provide you with skills such as innovative thinking, team-working and computing.
The pace of development of new medicines and greener sustainable processes is creating an ever-growing need for biochemical engineering graduates in the biotechnology, pharmaceutical, biofuels, chemical, environment and food industries.
You may be based in a university, or elect to work in company research and development activity that is involved in the design of facilities and the creation of safe materials. The programme teaches skills in systematic thinking and precise calculation, leading some graduates to enter the financial sector (particularly those companies which invest in healthcare).
UCL is committed to helping you get the best start after graduation. Read more about how UCL Careers and UCL Innovation and Enterprise can help you find employment or learn about entrepreneurship.
Fees and funding
The fees indicated are for undergraduate entry in the 2021/22 academic year. The UK fees shown are for the first year of the programme at UCL only. Fees for future years may be subject to an inflationary increase. The Overseas fees shown are the fees that will be charged to 2021/22 entrants for each year of study on the programme, unless otherwise indicated below.
- UK students
- £9,250 (2021/22)
- Overseas students
- £31,200 (2021/22)
Full details of UCL's tuition fees, tuition fee policy and potential increases to fees can be found on the UCL Students website.
A guide including rough estimates for these and other living expenses is included on the UCL Fees and funding pages. If you are concerned by potential additional costs for books, equipment, etc., please get in touch with the relevant departmental contact (details given on this page).
Various funding options are available, including student loans, scholarships and bursaries. UK students whose household income falls below a certain level may also be eligible for a non-repayable bursary or for certain scholarships. Please see the Fees and funding pages for more details.
The department has established a trust fund that supports five bursaries per year, each worth at least £1500. These are open to all applicants accepted onto undergraduate programmes.
Funding opportunities relevant to the department may appear in this section when they are available. Please check carefully or confirm with the programme contact to ensure they apply to this degree programme.
- Deadline: 2 July 2021
- Based on financial need
The Scholarships and Funding website lists scholarships and funding schemes available to UCL students. These may be open to all students, or restricted to specific nationalities, regions or academic department.
UCL is regulated by the Office for Students.
Page last modified on 15 April 2021